The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a multi-center, randomized, double-blind clinical trial to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ASKC200 in subjects with OA of the knees and determine the phase II recommended dose. Assigned doses will be applied for 60 minutes on each of four consecutive days.
Epistemonikos ID: 0a9d10ede3727109bace850c1c3552af7f24a808
First added on: Oct 01, 2024